A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Summary

The purpose of this study is to measure the safety and effectiveness of deucravatinib in participants with non-pustular palmoplantar psoriasis and genital psoriasis.

Timeline

Start

2023-10-09

Primary completion

2025-04-25

Completion

2025-04-25

Outcome

Outcome not reported

Stopped (Business): “Business objectives have changed”

Drugs

Indications